Skip to main content
Contact Us
Subscribe
E-Edition
77°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Novartis Ag ADR
(NY:
NVS
)
102.91
+0.06 (+0.06%)
Streaming Delayed Price
Updated: 10:32 AM EDT, May 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Novartis Ag ADR
< Previous
1
2
3
4
5
6
7
8
9
...
26
27
Next >
Week In Review: Everest Acquires Novel Autoimmune Therapy In $132 Million Agreement
September 23, 2023
Shanghai Everest Medicines acquired China/Asian rights to a novel therapy for autoimmune diseases from Kezar Life Sciences of South San Francisco in a deal worth $132.5 million. The company will make...
Via
Talk Markets
AI To Revolutionize Clinical Trials And Diagnostics
September 22, 2023
With the help of technology, the pharmaceutical industry is gaining new insights that are fueling the development of next generation of drugs while also speeding up clinical trials and improving...
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
From Years to Months: How AI is Shaping the Landscape of Clinical Trials
September 22, 2023
Pharmaceutical companies are harnessing artificial intelligence (AI) to speed up the traditionally arduous process of clinical trials, potentially saving both time and significant sums of money. These...
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Amazon Poaches Microsoft's Product Chief, Google And DoD Team Up For AI-Powered Microscope To Identify Cancer, Rocket Lab's 41st Mission Succumbed To Technical Issues: Today's Top Stories
September 19, 2023
Bloomberg
Via
Benzinga
2 Dividend Stocks to Buy and Hold Forever
September 13, 2023
These companies' prospects look secure.
Via
The Motley Fool
Price Over Earnings Overview: Novartis
September 01, 2023
Via
Benzinga
Chinese Drugmaker BeiGene And Novartis Move Out From Second Cancer Drug Pact
September 19, 2023
BeiGene Ltd (NASDAQ: BGNE) said it would regain rights to develop, manufacture, and commercialize Tevimbra (tislelizumab), its cancer drug, from Novartis AG (NYSE: NVS).
Via
Benzinga
AMC Stock Alert: Adam Aron Teases New Chocolate, Wine Brands for AMC
September 15, 2023
AMC Entertainment (AMC) stock is a hot topic on Friday after the movie theater chain's CEO teased that new products are on the way.
Via
InvestorPlace
Why Is Canopy Growth (CGC) Stock Up 14% Today?
September 15, 2023
Canopy Growth (CGC) stock is rising higher on Friday after the cannabis company announced it won't fund BioSteel Sports Nutrition any longer.
Via
InvestorPlace
Topics
Cannabis
Exposures
Cannabis
NVS Stock Alert: Novartis Shareholders Approve Sandoz Spinoff
September 15, 2023
Novartis (NVS) stock is rising higher on Friday after the company announced approval for the spinoff of its generic drugs business Sandoz.
Via
InvestorPlace
Instacart Mulls IPO Price Hike After Arm's Stellar Debut, UAW Launches Historic Simultaneous Strike, China Sanctions Lockheed Martin & Northrop Grumman Concerning Taiwan Arms Sales: Today's Top Stories
September 15, 2023
Wall Street Journal
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
Peering Into Novartis's Recent Short Interest
August 31, 2023
Via
Benzinga
Have Million-Dollar Gene Therapies Finally Reached An Inflection Point?
September 15, 2023
Gene therapies are clearing the FDA and reaching seriously ill patients. They could cost millions.
Via
Investor's Business Daily
Exposures
Product Safety
Sandoz Pushes Product Launch Plans As Novartis Shareholders Approve The Spin-Off
September 15, 2023
At an Extraordinary General Meeting, Novartis AG's (NYSE: NVS) shareholders
Via
Benzinga
AI Integration In Biotech & Pharma: Companies Positioned To Benefit
September 11, 2023
The convergence of artificial intelligence (AI) with the biotech and pharmaceutical sectors is ushering in a new era of innovation. AI is catalyzing transformations from drug discovery to patient care....
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Qualcomm-Apple's Chip Supply Agreement, Alleged Report About AstraZeneca CEO Sir Pascal Soriot's Intention To Step Down, Apple & Google Face Off in Antitrust Showdown: Today's Top Stories
September 11, 2023
Benzinga Qualcomm Announces Chip Supply Agreement With Apple
Via
Benzinga
Another Arthritis Blockbuster Drug Faces Generic Competition: Novartis' Sandoz Inks Pact With Samsung Bioepis
September 11, 2023
Sandoz, a generic and biosimilar medicines unit of Novartis AG (NYSE: NVS), has
Via
Benzinga
Could This Biosimilar Drug Be Novartis' Next Blockbuster?
September 05, 2023
Novartis expects to submit regulatory applications for its biosimilar soon.
Via
The Motley Fool
8 Pharma Stocks Affected by New Drug Price Negotiation Rules
September 02, 2023
Which companies have the most to lose now that Medicare can negotiate directly with them on the prices of some of the most widely used drugs?
Via
The Motley Fool
Biden Administration Vs. Big Pharma: What the Legal Showdown Means for Your Wallet
August 31, 2023
The Biden administration's move to lower drug prices has prompted a flurry of legal challenges.
Via
Benzinga
What Impact Will Medicare Price Negotiations Have on Big Pharma Stocks?
August 29, 2023
Investors appear to be yawning for the most part at the latest news on Medicare drug price negotiations.
Via
The Motley Fool
Important Data Ahead, Tesla Turning On Massive Nvidia Cluster, 10 Drugs Name For Price Cuts
August 29, 2023
To gain an edge, this is what you need to know today.
Via
Benzinga
Biden Targets Cancer, Diabetes Drugs In Controversial Medicare Price Battle
August 29, 2023
The Centers for Medicare and Medicaid Services unveiled the first ten drugs subject to price negotiations under President Joe Biden's Inflation Reduction Act, including:
Via
Benzinga
Blockbusters From AbbVie, Merck, Lilly Highlight List Of 10 Drugs Subject To Price Cuts
August 29, 2023
The Biden administration is planning to negotiate the prices of 10 drugs in 2026.
Via
Investor's Business Daily
3 AI Stocks With the Potential to Transform Your Financial Future
August 28, 2023
Are you looking to invest in AI stocks? Here are three picks with the potential to transform your financial future.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
3 Emerging Market Stocks to Buy in August
August 28, 2023
These three emerging market stocks to buy in August will have very strong, positive catalysts going forward.
Via
InvestorPlace
Exelixis' Lead Cancer Treatment Delivers Another Surprise, Though Analyst Finds Commercial Opportunity In Pancreatic Neuroendocrine Modest
August 24, 2023
Thursday, Exelixis Inc (NASDAQ: EXEL) announced that the Alliance for Clinical Trials in Oncology independent Data and Safety Monitoring Board (DSMB) unanimously recommended to unblind and stop the...
Via
Benzinga
Cheaper Version Of Blockbuster Arthritis Treatment Humira - CVS Health Teams With Sandoz
August 24, 2023
CVS Health Corp (NYSE: CVS) has launched Cordavis, a wholly-owned subsidiary, to work directly with manufacturers to commercialize and/or co-produce biosimilar
Via
Benzinga
Could This Medicine Be the Next Winner for Novartis?
August 23, 2023
The Swiss drugmaker recently reported that a drug candidate met the primary endpoints in phase 3 clinical trials.
Via
The Motley Fool
Gold Rush In Weight Loss Industry Impacts Retailers With Pharmacy Businesses
August 22, 2023
Retailers with pharmacy businesses, including major players like Walmart Inc (NYSE: WMT), Kroger Company (NYSE: KR), and Rite Aid Corp (NYSE:
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
26
27
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.